Avanos Medical, Inc. expects 2022 net sales to be between $830 million to $850 million, which assumes organic growth between 3% to 6%.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.09 USD | +0.79% | -3.15% | -14.89% |
05-13 | Avanos Medical, Inc. Appoints Sigfrido Delgado as Senior Vice President, Integrated Supply Chain | CI |
05-02 | Avanos Medical to Seek M&A Opportunities | CI |
1st Jan change | Capi. | |
---|---|---|
-14.89% | 824M | |
-3.19% | 105B | |
-4.14% | 67.55B | |
+15.49% | 46.71B | |
-6.00% | 46.39B | |
+4.77% | 40.68B | |
+22.10% | 31.63B | |
+11.75% | 24.35B | |
-8.53% | 23.46B | |
-12.33% | 21.95B |
- Stock Market
- Equities
- AVNS Stock
- News Avanos Medical, Inc.
- Avanos Medical, Inc. Provides Sales Guidance for the Full Year 2022